{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:42:06Z","timestamp":1790743326806,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1988,1,1]],"date-time":"1988-01-01T00:00:00Z","timestamp":567993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/bf00615223","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T05:43:59Z","timestamp":1101361439000},"page":"595-599","source":"Crossref","is-referenced-by-count":65,"title":["Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects"],"prefix":"10.1007","volume":"34","author":[{"given":"E.","family":"Perucca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Frigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"M\ufffdnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. E.","family":"Ohnhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2307\/2987883","volume":"31","author":"P Armitage","year":"1982","unstructured":"Armitage P, Hills M (1982) The two period cross-over trial. Statistician 31: 119?131","journal-title":"Statistician"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00563105","volume":"15","author":"DJ Back","year":"1979","unstructured":"Back DJ, Breckenridge AM, Crawford F, Maciver M, Orme ML'E, Park BK, Rowe PH, Smith E (1979) The effect of rifampicin on norethisterone pharmacokinetics. Eur J Clin Pharmacol 15: 193?197","journal-title":"Eur J Clin Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00562654","volume":"8","author":"HM Bolt","year":"1975","unstructured":"Bolt HM, Kappus H, Bolt M (1975) Effect of rifampicin treatment on the metabolism of oestradiol and 17-ethynyloes-tradiol by human liver microsomes. Eur J Clin Pharmacol 8: 301?307","journal-title":"Eur J Clin Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/cpt1977214470","volume":"21","author":"DD Breimer","year":"1977","unstructured":"Breimer DD, Zilly W, Richter E (1977) Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. Clin Pharmacol Ther 21: 470?481","journal-title":"Clin Pharmacol Ther"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/clpt.1980.115","volume":"27","author":"MJ Brodie","year":"1980","unstructured":"Brodie MJ, Boobis AR, Dollery CT, Hillyard CJ, Brown DJ, MacJntyre I, Park BK (1980) Rifampicin and vitamin D metabolism. Clin Pharmacol Ther 27: 810?814","journal-title":"Clin Pharmacol Ther"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/00498257909042337","volume":"9","author":"M Danhof","year":"1980","unstructured":"Danhof M, Krom D, Breimer DD (1980) Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment. Xenobiotica 9: 695?702","journal-title":"Xenobiotica"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.7164\/antibiotics.36.1502","volume":"36","author":"C Della Bruna","year":"1983","unstructured":"Della Bruna C, Schioppacassi C, Ungheri D, Jabes D, Morvillo E, Sanfilippo E (1983) LM 427, a new spiropiperidyl rifamycin: in vitro and in vivo studies. J Antibiot (Tokyo) 36: 1502?1506","journal-title":"J Antibiot"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0021-9673(00)93593-3","volume":"140","author":"M Eichelbaum","year":"1977","unstructured":"Eichelbaum M, Spahnbrucker N (1977) Rapid and sensitive method for the determination of antipyrine in biological fluids by high pressure liquid chromatography. J Chromatogr 140: 288?292","journal-title":"J Chromatogr"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000137550","volume":"23","author":"M Eichelbaum","year":"1981","unstructured":"Eichelbaum M, Sonntag B, Dengler HJ (1981) HPLC determination of antipyrine metabolites. Pharmacology 23: 192?202","journal-title":"Pharmacology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(83)91060-7","volume":"2","author":"RC Hastings","year":"1983","unstructured":"Hastings RC, Jacobson RR (1983) Activity of ansamycin against Mycobacterium leprae in mice. Lancet 2: 1079?1080","journal-title":"Lancet"},{"key":"CR11","first-page":"710","volume":"132","author":"LB Heifets","year":"1985","unstructured":"Heifets LB, Eiseman MD (1985) Determination of in vitro susceptibility of Mycobacteria to ansamycin. Am Rev Respir Dis 132: 710?711","journal-title":"Am Rev Respir Dis"},{"key":"CR12","first-page":"139","volume":"15","author":"EE Ohnhaus","year":"1979","unstructured":"Ohnhaus EE, Park BK (1979) Measurement of urinary 6-?-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of microsomal enzyme inducing capacity of antipyrine, phenobarbitone and rifampicin. Clin Pharmacol Ther 15: 139?145","journal-title":"Clin Pharmacol Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cpt1979255part1591","volume":"25","author":"EE Ohnhaus","year":"1979","unstructured":"Ohnhaus EE, Kirchof B, Peheim E (1979) Effect of enzyme induction on plasma lipids using antipyrine, phenobarbitone and rifampicin. Clin Pharmacol Ther 25: 591?597","journal-title":"Clin Pharmacol Ther"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0022-4731(78)90058-4","volume":"9","author":"BK Park","year":"1978","unstructured":"Park BK (1978) A direct radioimmunoassay for 6-?-hydroxycortisol in human urine. Steroid Biochem 9: 963?966","journal-title":"Steroid Biochem"},{"key":"CR15","first-page":"285","volume":"2","author":"E Perucca","year":"1978","unstructured":"Perucca E (1978) Clinical consequences of microsomal enzyme induction by antiepileptic drugs. Pharmacol Ther 2: 285?314","journal-title":"Pharmacol Ther"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00644969","volume":"16","author":"I Roots","year":"1979","unstructured":"Roots I, Holbe R, Hovermann W, Nigam S, Heinemeyer G, Hildebrandt AG (1979) Quantitative determination by HPLC of urinary 6-?-hydroxycortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs. Eur J Clin Pharmacol 16: 63?71","journal-title":"Eur J Clin Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ajcp\/60.5.684","volume":"60","author":"A Sanghvi","year":"1973","unstructured":"Sanghvi A, Wight C, Parikh B, Desai H (1973) Urinary 17-hydroxycorticosteroid determination with p-hydrazinobenzensulfonic acid phosphoric acid. Am J Clin Pathol 60: 684?690","journal-title":"Am J Clin Pathol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/clinchem\/15.2.124","volume":"15","author":"G Szasz","year":"1969","unstructured":"Szasz G (1969) A kinetic photometric method for serum gamma-gamma-glutamyl-transpeptidase. Clin Chem 15: 124?136","journal-title":"Clin Chem"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(74)91547-5","volume":"2","author":"EK Syvalahti","year":"1974","unstructured":"Syvalahti EK, Pihlajamaki KK, Iisalo EJ (1974) Rifampicin and drug metabolism. Lancet 2: 232?233","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00498258309052258","volume":"13","author":"MWE Teunissen","year":"1983","unstructured":"Teunissen MWE, Joeres RP, Vermeulen NPE, Breimer DD (1983) Influence of 9-hydroxyellipticine and 3-methyl-cholanthrene treatment on in vivo antipyrine metabolite formation in rats. Xenobiotica 13: 223?231","journal-title":"Xenobiotica"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.1984.tb02532.x","volume":"18","author":"MWE Teunissen","year":"1984","unstructured":"Teunissen MWE, Bakker W, Meerburg-Van der Torren JE, Breimer DD (1984) Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis. Br J Clin Pharmacol 18: 701?706","journal-title":"Br J Clin Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00637517","volume":"21","author":"EL Toverud","year":"1981","unstructured":"Toverud EL, Boobis AR, Brodie MJ, Murray S, Bennett PN, Whitmarsh V, Davies DS (1981) Differential induction of antipyrine metabolism by rifampicin. Eur J Clin Pharmacol 21: 155?160","journal-title":"Eur J Clin Pharmacol"},{"key":"CR23","first-page":"586","volume":"126","author":"CL Woodley","year":"1982","unstructured":"Woodley CL, Kilburn JO (1982) In vitro susceptibility of Mycobacterium Avium Complex and Mycobacterium tubercolosis strains to a spiropiperidyl rifamycin. Am Rev Respir Dis 126: 586?587","journal-title":"Am Rev Respir Dis"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00614021","volume":"9","author":"W Zilly","year":"1975","unstructured":"Zilly W, Breimer DD, Richter E (1975) Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance. Eur J Clin Pharmacol 9: 219?227","journal-title":"Eur J Clin Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-197702010-00005","volume":"2","author":"W Zilly","year":"1977","unstructured":"Zilly W, Breimer DD, Richter E (1977) Pharmacokinetic interactions with rifampicin. Clin Pharmacokinet 2: 61?70","journal-title":"Clin Pharmacokinet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00615223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00615223\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00615223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T08:39:04Z","timestamp":1585989544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00615223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1988]]}},"alternative-id":["BF00615223"],"URL":"https:\/\/doi.org\/10.1007\/bf00615223","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988]]}}}